跳至主要内容
临床试验/DRKS00023138
DRKS00023138已完成不适用

Paired analysis of microRNAs from whole blood cells in patients with lung diseases - miR-Sort II

Hummingbird Diagnostics GmbH0 个研究点目标入组 42 人开始时间: 2020年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
55 Years 至 80 Years(—)
性别
All

入选标准

  • The following patients are included: Group 1) Patients with suspected early stage lung cancer (stage I / II); and Group 2) patients with benign lung diseases (e.g. COPD or benign mass in the lungs); between the ages of 55 and 80 years (male or female). Further inclusion criteria are a current or ex-smoker status with = 30 pack years and with nicotine abstinence <15 years (if ex-smoker).

排除标准

  • Exclusion criteria are:
  • known chronic, infectious diseases (HIV, HCV, HBV)
  • an advanced cancer treated curatively in the past 5 years
  • immunomodulatory or neoadjuvant therapy that has already started
  • invasive diagnostics before inclusion in the study

研究者

相似试验